Tag: lead

MINNEAPOLIS and ST. PAUL, Minn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- As global demand for protein continues to rise, Minnesota-based MBOLD (an initiative of the GREATER MSP Partnership) and the Agricultural Utilization Research Institute (AURI) have launched the Protein Navigator, a new service designed to help protein-focused companies explore, enter and grow within Minnesota’s dynamic food and agriculture ecosystem.

NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the “Class Period”), of the important September 15, 2025 lead plaintiff deadline.

SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Rocket Pharmaceuticals class action lawsuit – captioned Ho v. Rocket Pharmaceuticals, Inc., No. 25-cv-10049 (D.N.J.) – seeks to represent purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities and charges Rocket Pharmaceuticals and one of Rocket Pharmaceuticals’ top executives with violations of the Securities Exchange Act of 1934. A subsequently filed case is captioned Yankov v. Rocket Pharmaceuticals, Inc., No. 25-cv-13532 (D.N.J.).

ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced financial results for the quarter ended June 30, 2025, and provided an update on its Symphony IL-6 test program and key operational milestones.

ROUGEMONT, Québec, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) today announced its financial results for the second quarter of 2025.

Investors can contact the law firm at no cost to learn more about recovering their losses

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial Corp. (TSX: TF) ("Timbercreek Financial" or the "Company") is pleased to announce a significant update to its credit facilities. On August 7, 2025, Timbercreek Financial entered into a second amending agreement to the third amended and restated credit agreement (the "New Credit Agreement") with a syndicate of nine lenders. The New Credit Agreement provides for revolving credit facilities totaling $600 million, including a $20 million swingline facility, up from the previous $510 million credit facility. The facility also includes a $100 million accordion feature for future expansion, subject to certain conditions. The term of the New Credit Agreement is two years, maturing on August 7, 2027. The Toronto-Dominion Bank will continue to act as sole lead arranger, sole book-runner, and administration agent.

- Halneuron^® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track as projected for Q4 2025 -